The global point-of-care molecular diagnostics market is gaining importance as healthcare providers increasingly prioritize rapid, accurate testing near the patient. These diagnostic platforms help clinicians identify infections and other medical conditions without depending entirely on centralized laboratory facilities, supporting faster clinical decisions and timely patient management....
The global molecular diagnostics market is witnessing steady expansion as healthcare providers increasingly prioritize early disease detection, accurate diagnosis, and personalized treatment. The Molecular Diagnostics Market was valued at USD 18.8 billion in 2025 and is projected to increase from USD 19.4 billion in 2026 to USD 25.6 billion by 2033, registering a CAGR of 4.1% from 2026 to 2033....
The global Molecular Diagnostics Market is projected to grow from USD 19.4 billion in 2026 to USD 25.6 billion by 2033, registering a 4.1% CAGR. The market reached USD 18.8 billion in 2025, with North America accounting for the largest regional share at 44.1%.
The industry's growth reflects increasing demand for precise diagnostics, technological advancement,...
The global Molecular Diagnostics Market size was valued at USD 18.8 billion in 2025 and is projected to grow from USD 19.4 billion in 2026 to USD 25.6 billion by 2033, registering a CAGR of 4.1% from 2026 to 2033. North America dominated the market with a 44.1% revenue share in 2025. The growth of the molecular diagnostics industry is driven by increasing...
The global Blood Group Typing Market was valued at USD 2.3 billion in 2025 and is projected to reach USD 5.6 billion by 2033, growing at a CAGR of 12.0% from 2026 to 2033. The market is expanding rapidly due to the increasing burden of chronic diseases, rising surgical procedures, organ transplantation, and growing awareness regarding transfusion safety. Blood...
The global Blood-Based Biomarker For Alzheimer’s Disease Diagnostics Market was valued at USD 169.2 million in 2025 and is projected to grow from USD 194.8 million in 2026 to USD 529.9 million by 2033, registering a CAGR of 17.4% from 2026 to 2033. North America dominated the global market with a 43.0% revenue share in 2025, driven by regulatory approvals, expanding clinical...
Infectious Disease Testing Market
The Infectious Disease Testing Market is experiencing strong expansion driven by the rising global burden of infectious diseases, increasing demand for early diagnosis, and advancements in molecular diagnostic technologies. The market size was valued at USD 28 billion in 2025 and is projected to grow from USD 30 billion in 2026 to USD...
Global analytical reagents market was valued at USD 9.8 billion in 2025 and is projected to reach USD 14.5 billion by 2034, exhibiting a remarkable CAGR of 4.4% during the forecast period.
Analytical reagents, encompassing high鈥憄urity chemicals, solvents, standards and assay kits, have transitioned from niche laboratory consumables to pivotal enablers of modern scientific discovery. Their...
Fast, accurate, and accessible diagnostic testing has become a cornerstone of modern healthcare, enabling clinicians to detect diseases quickly and initiate timely treatment. Among the technologies transforming point-of-care diagnostics, lateral flow assays (LFAs) have gained widespread recognition for their simplicity, affordability, and rapid results. These diagnostic devices are extensively...
The global infectious disease testing market is experiencing significant growth due to the increasing prevalence of infectious diseases, rising awareness regarding early disease diagnosis, and growing adoption of advanced diagnostic technologies. Infectious disease testing plays a critical role in detecting bacterial, viral, fungal, and parasitic infections, enabling timely treatment...
The global syphilis testing market size was estimated at USD 1.57 billion in 2025 and is projected to reach USD 2.32 billion by 2033, growing at a CAGR of 5.23% from 2026 to 2033. The market is witnessing sustained growth due to the rising prevalence of syphilis infections, increasing congenital syphilis cases, expanding public health screening initiatives, and growing adoption of...
The competitive landscape of the global in vitro diagnostics (IVD) market reflects a structured yet evolving ecosystem, where a limited number of multinational corporations coexist with a growing base of specialized innovators. As per the study published by MarkNtel Advisors, the market features a defined set of leading companies whose strategies and capabilities significantly influence...